Quest Diagnostics Inc
(DGX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 7,435,000 | 7,146,000 | 7,383,000 | 7,392,000 | 7,260,120 |
| Cost of Goods | 4,637,000 | 4,326,000 | 4,365,000 | 4,363,000 | 4,275,535 |
| Gross Profit | 2,798,000 | 2,820,000 | 3,018,000 | 3,029,000 | 2,984,585 |
| Operating Expenses | 1,815,000 | 1,345,000 | 1,817,000 | 2,042,000 | 1,701,537 |
| Operating Income | 983,000 | 1,475,000 | 1,201,000 | 987,000 | 1,283,583 |
| Interest Expense | 164,000 | 159,000 | 165,000 | 170,000 | 143,467 |
| Other Income | 30,000 | 32,000 | 32,000 | 32,000 | 34,868 |
| Pre-tax Income | 849,000 | 1,348,000 | 1,068,000 | 849,000 | 1,174,984 |
| Income Tax | 262,000 | 500,000 | 402,000 | 355,000 | 430,127 |
| Net Income Continuous | 587,000 | 848,000 | 666,000 | 494,000 | 744,857 |
| Net Income Discontinuous | 5,000 | 35,000 | -74,000 | 12,000 | 12,160 |
| Minority Interests | 36,000 | 34,000 | 36,000 | 35,000 | 36,123 |
| Net Income | $556,000 | $849,000 | $556,000 | $471,000 | $720,894 |
| EPS Basic Total Ops | 3.83 | 5.58 | 3.49 | 2.95 | 4.08 |
| EPS Basic Continuous Ops | 3.80 | 5.35 | 3.96 | 2.88 | 4.01 |
| EPS Basic Discontinuous Ops | 0.03 | 0.23 | -0.47 | 0.07 | 0.07 |
| EPS Diluted Total Ops | 3.81 | 5.54 | 3.46 | 2.92 | 4.05 |
| EPS Diluted Continuous Ops | 3.78 | 5.31 | 3.92 | 2.85 | 3.98 |
| EPS Diluted Discontinuous Ops | 0.03 | 0.23 | -0.46 | 0.07 | 0.07 |
| EBITDA(a) | $1,297,000 | $1,758,000 | $1,488,000 | $1,268,000 | $1,537,547 |